NYC TCTTAC
Menu
Home
About
About NYC TCTTAC
Addressing Tobacco
About our Roadmap
Meet the Team
Training
About Our Training
Upcoming Trainings
Resources
Resources & Tools
Webinars
Technical Assistance
Contact
Resources & Tools
Resources & Tools > Tag >
Notice
FDA Modifications to Labeling Nicotine Replacement Therapy Products
FDA Revised Drug Safety Communication on Chantix & Zyban
Letter from OMH and DOHMH describing unrestricted Medicaid coverage for treating tobacco use